A multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.
Yan Li, MD
Advertisement
Articles by Yan Li, MD
Advertisement
Latest Updated Articles
- Breast Cancer Multigene Testing Trends and Impact on Chemotherapy Use
Published: May 17th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Contributor: American Patients vs Foreign Governments—A Tale of 2 Value Sets
2
Asundexian Cuts Recurrent Stroke Risk Without More Bleeding: Mukul Sharma, MD, MSc
3
Faricimab Safe, Effective for Use in Treating nAMD in Treatment-Naive Eyes
4
Visceral Adiposity May Explain Much of CKD Seen in Older Adults With HFpEF
5